LPL Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

LPL Financial’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-15,200	Closed	-$247K	–	2752
2014 Q1	$247K	Buy	+15,200	New	+$216K	﹤0.01%	2281

Other funds holding VNDA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

SCA

Signpost Capital Advisors New York $34.2M AUM 5.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LPL Financial's VNDA Position: Q2 2014 in Review

LPL Financial sold out of Vanda Pharmaceuticals (VNDA) in Q2 2014, closing a stake of 15,200 shares — an estimated $247K sold.

LPL Financial first reported a position in VNDA in Q1 2014 and held it in 1 quarter. The position peaked at $247K in Q1 2014. 110 funds tracked by Wall St. Rank hold VNDA as of Q2 2014.

LPL Financial reported no remaining Vanda Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
LPL Financial sold 15,200 Vanda Pharmaceuticals shares in Q2 2014, an estimated $247K.
LPL Financial first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 1 quarter.
LPL Financial's Vanda Pharmaceuticals position peaked at $247K in Q1 2014.
110 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2014.

Based on LPL Financial's 13F filing for Q2 2014, filed 5 Aug 2014.